Share this
Shoreline Enters Partnership with Kite
Shoreline Enters Collaboration with BeiGene
Horizon Pharma Acquisition of Crealta Holdings for $510 Million
Horizon Pharma Buys River Vision for $145 Million and Unspecified Earn-Out
Synthorx to Sell to Sanofi for $2.5 Billion
ArcherDX Agrees to Combine With Invitae in $2.7 Billion Deal
Rodeo Therapeutics Agrees to Sell to Amgen for $721 Million
Shoreline Biosciences Enters Collaboration With BeiGene to Develop Genetically Modified Cell Therapies
Resolution Bio Sells to Agilent
Genomatica Joint Venture with Unilever
Sixth Street Invests in Blueprint Medicines
Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals
Oyster Point Pharma to Be Acquired by Viatris
Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion
CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion